Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 50 entries
Sorted by: Best Match Show Resources per page
Informed consent in deep brain stimulation - ethical considerations in a stress field of pride and prejudice.

Frontiers in integrative neuroscience

Skuban T, Hardenacke K, Woopen C, Kuhn J.
PMID: 21559309
Front Integr Neurosci. 2011 Apr 29;5:7. doi: 10.3389/fnint.2011.00007. eCollection 2011.

No abstract available.

Cite
Skuban T, Hardenacke K, Woopen C, et al. Informed consent in deep brain stimulation - ethical considerations in a stress field of pride and prejudice. Front Integr Neurosci. 2011;5:7doi: 10.3389/fnint.2011.00007.
Skuban, T., Hardenacke, K., Woopen, C., & Kuhn, J. (2011). Informed consent in deep brain stimulation - ethical considerations in a stress field of pride and prejudice. Frontiers in integrative neuroscience, 57. https://doi.org/10.3389/fnint.2011.00007
Skuban, Tobias, et al. "Informed consent in deep brain stimulation - ethical considerations in a stress field of pride and prejudice." Frontiers in integrative neuroscience vol. 5 (2011): 7. doi: https://doi.org/10.3389/fnint.2011.00007
Skuban T, Hardenacke K, Woopen C, Kuhn J. Informed consent in deep brain stimulation - ethical considerations in a stress field of pride and prejudice. Front Integr Neurosci. 2011 Apr 29;5:7. doi: 10.3389/fnint.2011.00007. eCollection 2011. PMID: 21559309; PMCID: PMC3085861.
Copy Download .nbib Format: NLM
Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92].

Schizophrenia research

Correll CU, Skuban A, Hobart M, Ouyang J, Weiller E, Weiss C, Kane JM.
PMID: 28351543
Schizophr Res. 2017 Dec;190:191-194. doi: 10.1016/j.schres.2017.02.030. Epub 2017 Mar 25.

No abstract available.

Cite
Correll CU, Skuban A, Hobart M, et al. Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]. Schizophr Res. 2017;190:191-194doi: 10.1016/j.schres.2017.02.030.
Correll, C. U., Skuban, A., Hobart, M., Ouyang, J., Weiller, E., Weiss, C., & Kane, J. M. (2017). Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]. Schizophrenia research, 190191-194. https://doi.org/10.1016/j.schres.2017.02.030
Correll, Christoph U, et al. "Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]." Schizophrenia research vol. 190 (2017): 191-194. doi: https://doi.org/10.1016/j.schres.2017.02.030
Correll CU, Skuban A, Hobart M, Ouyang J, Weiller E, Weiss C, Kane JM. Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]. Schizophr Res. 2017 Dec;190:191-194. doi: 10.1016/j.schres.2017.02.030. Epub 2017 Mar 25. PMID: 28351543.
Copy Download .nbib Format: NLM
Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer.

Practical radiation oncology

Melancon AD, Lee AK, Kudchadker R, Zhang L, Tucker SL, Kuban D, Dong L.
PMID: 24674406
Pract Radiat Oncol. 2013 Oct-Dec;3(4):329-36. doi: 10.1016/j.prro.2012.10.004. Epub 2012 Nov 09.

PURPOSE: To characterize anatomic variation during neoadjuvant androgen deprivation (NAD) and determine a treatment planning strategy to maintain acceptable normal tissue dose while treating potential microscopic disease in the original (pre-NAD) tumor bed.METHODS AND MATERIALS: We retrospectively examined the...

Cite
Melancon AD, Lee AK, Kudchadker R, et al. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Pract Radiat Oncol. 2012;3(4):329-36doi: 10.1016/j.prro.2012.10.004.
Melancon, A. D., Lee, A. K., Kudchadker, R., Zhang, L., Tucker, S. L., Kuban, D., & Dong, L. (2013). Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Practical radiation oncology, 3(4), 329-36. https://doi.org/10.1016/j.prro.2012.10.004
Melancon, Adam D, et al. "Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer." Practical radiation oncology vol. 3,4 (2013): 329-36. doi: https://doi.org/10.1016/j.prro.2012.10.004
Melancon AD, Lee AK, Kudchadker R, Zhang L, Tucker SL, Kuban D, Dong L. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Pract Radiat Oncol. 2013 Oct-Dec;3(4):329-36. doi: 10.1016/j.prro.2012.10.004. Epub 2012 Nov 09. PMID: 24674406.
Copy Download .nbib Format: NLM
TMEM67, TMEM237, and Embigin in Complex With Monocarboxylate Transporter MCT1 Are Unique Components of the Photoreceptor Outer Segment Plasma Membrane.

Molecular & cellular proteomics : MCP

Skiba NP, Cady MA, Molday L, Han JYS, Lewis TR, Spencer WJ, Thompson WJ, Hiles S, Philp NJ, Molday RS, Arshavsky VY.
PMID: 33933680
Mol Cell Proteomics. 2021;20:100088. doi: 10.1016/j.mcpro.2021.100088. Epub 2021 Apr 30.

The outer segment (OS) organelle of vertebrate photoreceptors is a highly specialized cilium evolved to capture light and initiate light response. The plasma membrane which envelopes the OS plays vital and diverse roles in supporting photoreceptor function and health....

Cite
Skiba NP, Cady MA, Molday L, et al. TMEM67, TMEM237, and Embigin in Complex With Monocarboxylate Transporter MCT1 Are Unique Components of the Photoreceptor Outer Segment Plasma Membrane. Mol Cell Proteomics. 2021;20:100088doi: 10.1016/j.mcpro.2021.100088.
Skiba, N. P., Cady, M. A., Molday, L., Han, J. Y. S., Lewis, T. R., Spencer, W. J., Thompson, W. J., Hiles, S., Philp, N. J., Molday, R. S., & Arshavsky, V. Y. (2021). TMEM67, TMEM237, and Embigin in Complex With Monocarboxylate Transporter MCT1 Are Unique Components of the Photoreceptor Outer Segment Plasma Membrane. Molecular & cellular proteomics : MCP, 20100088. https://doi.org/10.1016/j.mcpro.2021.100088
Skiba, Nikolai P, et al. "TMEM67, TMEM237, and Embigin in Complex With Monocarboxylate Transporter MCT1 Are Unique Components of the Photoreceptor Outer Segment Plasma Membrane." Molecular & cellular proteomics : MCP vol. 20 (2021): 100088. doi: https://doi.org/10.1016/j.mcpro.2021.100088
Skiba NP, Cady MA, Molday L, Han JYS, Lewis TR, Spencer WJ, Thompson WJ, Hiles S, Philp NJ, Molday RS, Arshavsky VY. TMEM67, TMEM237, and Embigin in Complex With Monocarboxylate Transporter MCT1 Are Unique Components of the Photoreceptor Outer Segment Plasma Membrane. Mol Cell Proteomics. 2021;20:100088. doi: 10.1016/j.mcpro.2021.100088. Epub 2021 Apr 30. PMID: 33933680; PMCID: PMC8167285.
Copy Download .nbib Format: NLM
Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report.

Case reports in obstetrics and gynecology

Haninger-Vacariu N, El-Hadi S, Pauler U, Foretnik M, Kain R, Prohászka Z, Schmidt A, Skuban N, Barth JA, Sunder-Plassmann G.
PMID: 31934472
Case Rep Obstet Gynecol. 2019 Dec 21;2019:1030259. doi: 10.1155/2019/1030259. eCollection 2019.

Our patient was a 37-year-old woman with Fabry disease (

Cite
Haninger-Vacariu N, El-Hadi S, Pauler U, et al. Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report. Case Rep Obstet Gynecol. 2019;2019:1030259doi: 10.1155/2019/1030259.
Haninger-Vacariu, N., El-Hadi, S., Pauler, U., Foretnik, M., Kain, R., Prohászka, Z., Schmidt, A., Skuban, N., Barth, J. A., & Sunder-Plassmann, G. (2019). Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report. Case reports in obstetrics and gynecology, 20191030259. https://doi.org/10.1155/2019/1030259
Haninger-Vacariu, Natalja, et al. "Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report." Case reports in obstetrics and gynecology vol. 2019 (2019): 1030259. doi: https://doi.org/10.1155/2019/1030259
Haninger-Vacariu N, El-Hadi S, Pauler U, Foretnik M, Kain R, Prohászka Z, Schmidt A, Skuban N, Barth JA, Sunder-Plassmann G. Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report. Case Rep Obstet Gynecol. 2019 Dec 21;2019:1030259. doi: 10.1155/2019/1030259. eCollection 2019. PMID: 31934472; PMCID: PMC6942789.
Copy Download .nbib Format: NLM
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease.

Molecular genetics and metabolism reports

Bichet DG, Torra R, Wallace E, Hughes D, Giugliani R, Skuban N, Krusinska E, Feldt-Rasmussen U, Schiffmann R, Nicholls K.
PMID: 34401344
Mol Genet Metab Rep. 2021 Aug 04;28:100786. doi: 10.1016/j.ymgmr.2021.100786. eCollection 2021 Sep.

The effect of migalastat on long-term renal outcomes in enzyme replacement therapy (ERT)-naive and ERT-experienced patients with Fabry disease is not well defined. An integrated posthoc analysis of the phase 3 clinical trials and open-label extension studies was conducted...

Cite
Bichet DG, Torra R, Wallace E, et al. Long-term follow-up of renal function in patients treated with migalastat for Fabry disease. Mol Genet Metab Rep. 2021;28:100786doi: 10.1016/j.ymgmr.2021.100786.
Bichet, D. G., Torra, R., Wallace, E., Hughes, D., Giugliani, R., Skuban, N., Krusinska, E., Feldt-Rasmussen, U., Schiffmann, R., & Nicholls, K. (2021). Long-term follow-up of renal function in patients treated with migalastat for Fabry disease. Molecular genetics and metabolism reports, 28100786. https://doi.org/10.1016/j.ymgmr.2021.100786
Bichet, Daniel G, et al. "Long-term follow-up of renal function in patients treated with migalastat for Fabry disease." Molecular genetics and metabolism reports vol. 28 (2021): 100786. doi: https://doi.org/10.1016/j.ymgmr.2021.100786
Bichet DG, Torra R, Wallace E, Hughes D, Giugliani R, Skuban N, Krusinska E, Feldt-Rasmussen U, Schiffmann R, Nicholls K. Long-term follow-up of renal function in patients treated with migalastat for Fabry disease. Mol Genet Metab Rep. 2021 Aug 04;28:100786. doi: 10.1016/j.ymgmr.2021.100786. eCollection 2021 Sep. PMID: 34401344; PMCID: PMC8353473.
Copy Download .nbib Format: NLM
Role of scavenger receptors in silica nanoparticle-induced cytokine responses in bronchial epithelial cells.

Toxicology letters

Refsnes M, Skuland T, Øvrevik J, Låg M.
PMID: 34653535
Toxicol Lett. 2021 Oct 12;353:100-106. doi: 10.1016/j.toxlet.2021.10.004. Epub 2021 Oct 12.

A major challenge in nanoparticle (NP) research is to elucidate how NPs activate initial targets in cells, leading to cytotoxicity and inflammation. We have previously shown that silica (Si)NPs induce pro-inflammatory responses in bronchial epithelial cells (BEAS-2B) via mechanisms...

Cite
Refsnes M, Skuland T, Øvrevik J, et al. Role of scavenger receptors in silica nanoparticle-induced cytokine responses in bronchial epithelial cells. Toxicol Lett. 2021;353:100-106doi: 10.1016/j.toxlet.2021.10.004.
Refsnes, M., Skuland, T., Øvrevik, J., & Låg, M. (2021). Role of scavenger receptors in silica nanoparticle-induced cytokine responses in bronchial epithelial cells. Toxicology letters, 353100-106. https://doi.org/10.1016/j.toxlet.2021.10.004
Refsnes, Magne, et al. "Role of scavenger receptors in silica nanoparticle-induced cytokine responses in bronchial epithelial cells." Toxicology letters vol. 353 (2021): 100-106. doi: https://doi.org/10.1016/j.toxlet.2021.10.004
Refsnes M, Skuland T, Øvrevik J, Låg M. Role of scavenger receptors in silica nanoparticle-induced cytokine responses in bronchial epithelial cells. Toxicol Lett. 2021 Oct 12;353:100-106. doi: 10.1016/j.toxlet.2021.10.004. Epub 2021 Oct 12. PMID: 34653535.
Copy Download .nbib Format: NLM
Influence of Incubation Time on Ortho-Toluidine Blue Mediated Antimicrobial Photodynamic Therapy Directed against Selected .

International journal of molecular sciences

Wiench R, Nowicka J, Pajączkowska M, Kuropka P, Skaba D, Kruczek-Kazibudzka A, Kuśka-Kiełbratowska A, Grzech-Leśniak K.
PMID: 34681632
Int J Mol Sci. 2021 Oct 11;22(20). doi: 10.3390/ijms222010971.

(1) Background and the aim: The appropriate incubation time in the antimicrobial photodynamic therapy protocol seems to have a huge impact on the efficacy of this process. This is particularly important in relation to

Cite
Wiench R, Nowicka J, Pajączkowska M, et al. Influence of Incubation Time on Ortho-Toluidine Blue Mediated Antimicrobial Photodynamic Therapy Directed against Selected . Int J Mol Sci. 2021;22(20)doi: 10.3390/ijms222010971.
Wiench, R., Nowicka, J., Pajączkowska, M., Kuropka, P., Skaba, D., Kruczek-Kazibudzka, A., Kuśka-Kiełbratowska, A., & Grzech-Leśniak, K. (2021). Influence of Incubation Time on Ortho-Toluidine Blue Mediated Antimicrobial Photodynamic Therapy Directed against Selected . International journal of molecular sciences, 22(20), . https://doi.org/10.3390/ijms222010971
Wiench, Rafał, et al. "Influence of Incubation Time on Ortho-Toluidine Blue Mediated Antimicrobial Photodynamic Therapy Directed against Selected ." International journal of molecular sciences vol. 22,20 (2021). doi: https://doi.org/10.3390/ijms222010971
Wiench R, Nowicka J, Pajączkowska M, Kuropka P, Skaba D, Kruczek-Kazibudzka A, Kuśka-Kiełbratowska A, Grzech-Leśniak K. Influence of Incubation Time on Ortho-Toluidine Blue Mediated Antimicrobial Photodynamic Therapy Directed against Selected . Int J Mol Sci. 2021 Oct 11;22(20). doi: 10.3390/ijms222010971. PMID: 34681632; PMCID: PMC8536188.
Copy Download .nbib Format: NLM
Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety.

Food control

Mihalache OA, Møretrø T, Borda D, Dumitraşcu L, Neagu C, Nguyen-The C, Maître I, Didier P, Teixeira P, Lopes Junqueira LO, Truninger M, Izsó T, Kasza G, Skuland SE, Langsrud S, Nicolau AI.
PMID: 34980942
Food Control. 2022 Jan;131:108433. doi: 10.1016/j.foodcont.2021.108433.

Our paper emphasizes the importance of the kitchen layout in facilitating consumers' food hygiene practices. A significant correlation was found between the sink placement (inside or outside the kitchen) and hygienic practices during food handling based on a survey...

Cite
Mihalache OA, Møretrø T, Borda D, et al. Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety. Food Control. 2022;131:108433doi: 10.1016/j.foodcont.2021.108433.
Mihalache, O. A., Møretrø, T., Borda, D., Dumitraşcu, L., Neagu, C., Nguyen-The, C., Maître, I., Didier, P., Teixeira, P., Lopes Junqueira, L. O., Truninger, M., Izsó, T., Kasza, G., Skuland, S. E., Langsrud, S., & Nicolau, A. I. (2022). Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety. Food control, 131108433. https://doi.org/10.1016/j.foodcont.2021.108433
Mihalache, Octavian Augustin, et al. "Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety." Food control vol. 131 (2022): 108433. doi: https://doi.org/10.1016/j.foodcont.2021.108433
Mihalache OA, Møretrø T, Borda D, Dumitraşcu L, Neagu C, Nguyen-The C, Maître I, Didier P, Teixeira P, Lopes Junqueira LO, Truninger M, Izsó T, Kasza G, Skuland SE, Langsrud S, Nicolau AI. Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety. Food Control. 2022 Jan;131:108433. doi: 10.1016/j.foodcont.2021.108433. PMID: 34980942; PMCID: PMC8474550.
Copy Download .nbib Format: NLM
Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety.

Food control

Mihalache OA, Møretrø T, Borda D, Dumitraşcu L, Neagu C, Nguyen-The C, Maître I, Didier P, Teixeira P, Lopes Junqueira LO, Truninger M, Izsó T, Kasza G, Skuland SE, Langsrud S, Nicolau AI.
PMID: 34980942
Food Control. 2022 Jan;131:108433. doi: 10.1016/j.foodcont.2021.108433.

Our paper emphasizes the importance of the kitchen layout in facilitating consumers' food hygiene practices. A significant correlation was found between the sink placement (inside or outside the kitchen) and hygienic practices during food handling based on a survey...

Cite
Mihalache OA, Møretrø T, Borda D, et al. Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety. Food Control. 2022;131:108433doi: 10.1016/j.foodcont.2021.108433.
Mihalache, O. A., Møretrø, T., Borda, D., Dumitraşcu, L., Neagu, C., Nguyen-The, C., Maître, I., Didier, P., Teixeira, P., Lopes Junqueira, L. O., Truninger, M., Izsó, T., Kasza, G., Skuland, S. E., Langsrud, S., & Nicolau, A. I. (2022). Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety. Food control, 131108433. https://doi.org/10.1016/j.foodcont.2021.108433
Mihalache, Octavian Augustin, et al. "Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety." Food control vol. 131 (2022): 108433. doi: https://doi.org/10.1016/j.foodcont.2021.108433
Mihalache OA, Møretrø T, Borda D, Dumitraşcu L, Neagu C, Nguyen-The C, Maître I, Didier P, Teixeira P, Lopes Junqueira LO, Truninger M, Izsó T, Kasza G, Skuland SE, Langsrud S, Nicolau AI. Kitchen layouts and consumers' food hygiene practices: Ergonomics versus safety. Food Control. 2022 Jan;131:108433. doi: 10.1016/j.foodcont.2021.108433. PMID: 34980942; PMCID: PMC8474550.
Copy Download .nbib Format: NLM
Evidence-Based Health Informatics as the Foundation for the COVID-19 Response: A Joint Call for Action.

Methods of information in medicine

Fernandez-Luque L, Kushniruk AW, Georgiou A, Basu A, Petersen C, Ronquillo C, Paton C, Nøhr C, Kuziemsky CE, Alhuwail D, Skiba D, Huesing E, Gabarron E, Borycki EM, Magrabi F, Denecke K, Peute LWP, Topaz M, Al-Shorbaji N, Lacroix P, Marcilly R, Cornet R, Gogia SB, Kobayashi S, Iyengar S, Deserno TM, Mettler T, Vimarlund V, Zhu X.
PMID: 33975375
Methods Inf Med. 2020 Dec;59(6):183-192. doi: 10.1055/s-0041-1726414. Epub 2021 May 11.

BACKGROUND: As a major public health crisis, the novel coronavirus disease 2019 (COVID-19) pandemic demonstrates the urgent need for safe, effective, and evidence-based implementations of digital health. The urgency stems from the frequent tendency to focus attention on seemingly...

Cite
Fernandez-Luque L, Kushniruk AW, Georgiou A, et al. Evidence-Based Health Informatics as the Foundation for the COVID-19 Response: A Joint Call for Action. Methods Inf Med. 2021;59(6):183-192doi: 10.1055/s-0041-1726414.
Fernandez-Luque, L., Kushniruk, A. W., Georgiou, A., Basu, A., Petersen, C., Ronquillo, C., Paton, C., Nøhr, C., Kuziemsky, C. E., Alhuwail, D., Skiba, D., Huesing, E., Gabarron, E., Borycki, E. M., Magrabi, F., Denecke, K., Peute, L. W. P., Topaz, M., Al-Shorbaji, N., Lacroix, P., Marcilly, R., Cornet, R., Gogia, S. B., Kobayashi, S., Iyengar, S., Deserno, T. M., Mettler, T., Vimarlund, V., & Zhu, X. (2020). Evidence-Based Health Informatics as the Foundation for the COVID-19 Response: A Joint Call for Action. Methods of information in medicine, 59(6), 183-192. https://doi.org/10.1055/s-0041-1726414
Fernandez-Luque, Luis, et al. "Evidence-Based Health Informatics as the Foundation for the COVID-19 Response: A Joint Call for Action." Methods of information in medicine vol. 59,6 (2020): 183-192. doi: https://doi.org/10.1055/s-0041-1726414
Fernandez-Luque L, Kushniruk AW, Georgiou A, Basu A, Petersen C, Ronquillo C, Paton C, Nøhr C, Kuziemsky CE, Alhuwail D, Skiba D, Huesing E, Gabarron E, Borycki EM, Magrabi F, Denecke K, Peute LWP, Topaz M, Al-Shorbaji N, Lacroix P, Marcilly R, Cornet R, Gogia SB, Kobayashi S, Iyengar S, Deserno TM, Mettler T, Vimarlund V, Zhu X. Evidence-Based Health Informatics as the Foundation for the COVID-19 Response: A Joint Call for Action. Methods Inf Med. 2020 Dec;59(6):183-192. doi: 10.1055/s-0041-1726414. Epub 2021 May 11. PMID: 33975375; PMCID: PMC8279811.
Copy Download .nbib Format: NLM
The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary.

Medycyna pracy

Hüpsch-Marzec H, Dziedzic A, Skaba D, Tanasiewicz M.
PMID: 34596170
Med Pr. 2021 Dec 22;72(6):685-692. doi: 10.13075/mp.5893.01135. Epub 2021 Sep 16.

Virus-induced oral abnormalities, occurring especially in severe COVID-19 cases of hospitalized patients, have various characteristics and clinical features being, either directly or indirectly, related to SARS-CoV-2 infection. Deregulation of the immune system as a result of SARS-CoV-2 infection may...

Cite
Hüpsch-Marzec H, Dziedzic A, Skaba D, et al. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary. Med Pr. 2021;72(6):685-692doi: 10.13075/mp.5893.01135.
Hüpsch-Marzec, H., Dziedzic, A., Skaba, D., & Tanasiewicz, M. (2021). The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary. Medycyna pracy, 72(6), 685-692. https://doi.org/10.13075/mp.5893.01135
Hüpsch-Marzec, Hanna, et al. "The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary." Medycyna pracy vol. 72,6 (2021): 685-692. doi: https://doi.org/10.13075/mp.5893.01135
Hüpsch-Marzec H, Dziedzic A, Skaba D, Tanasiewicz M. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary. Med Pr. 2021 Dec 22;72(6):685-692. doi: 10.13075/mp.5893.01135. Epub 2021 Sep 16. PMID: 34596170.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 50 entries